Can I receive the shingles vaccine while taking Imuran (azathioprine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Get the Shingles Vaccine While Taking Imuran?

Yes, you can receive the recombinant shingles vaccine (Shingrix) while taking Imuran (azathioprine), but you must NOT receive the live-attenuated vaccine (Zostavax). 1, 2

Vaccine Selection: Only Shingrix Is Appropriate

The recombinant zoster vaccine (Shingrix) is the only acceptable shingles vaccine for patients on azathioprine. 2, 3 This is a non-live vaccine containing only a viral protein fragment with an adjuvant, making it safe for immunosuppressed individuals. 3, 4

The live-attenuated vaccine (Zostavax) is absolutely contraindicated in patients taking azathioprine due to the theoretical risk of disseminated vaccine-strain infection. 1, 2

Dosing Guidelines Based on Your Azathioprine Dose

If Your Azathioprine Dose Is ≤3 mg/kg/day:

According to current ACIP and UK guidelines, you fall into the "low-level immunosuppression" category, which provides two options: 1

  • Option 1 (Preferred): Receive the recombinant vaccine (Shingrix) as a 2-dose series, with doses given 2-6 months apart (minimum 4 weeks). 2, 5 This is the safest and most effective approach.

  • Option 2 (Less preferred): In the UK, the live-attenuated vaccine may be considered for those on azathioprine ≤3 mg/kg/day after careful risk-benefit discussion, but this contradicts broader international guidance and is not recommended in most settings. 1

The recombinant vaccine (Shingrix) is strongly preferred regardless of your azathioprine dose because it offers superior efficacy (>90% vs 51% for Zostavax), longer-lasting protection, and no infection risk. 2, 4

If Your Azathioprine Dose Is >3 mg/kg/day:

You are considered significantly immunosuppressed, and only Shingrix is appropriate—the live vaccine is absolutely contraindicated. 1, 2

Practical Administration Algorithm

Step 1: Confirm Your Eligibility

  • Age ≥50 years: Standard recommendation for all adults on immunosuppressants. 2, 5
  • Age 18-49 years on azathioprine: You qualify for Shingrix as an immunocompromised adult. 2, 3

Step 2: Timing Considerations

Ideal scenario: Complete the 2-dose Shingrix series before starting azathioprine, with the vaccine given at least 4 weeks before initiating immunosuppression. 1, 2 This maximizes immune response.

Already on azathioprine (your situation): You can receive Shingrix at any time while taking azathioprine. 2, 3 Do not delay vaccination—the protection outweighs any theoretical reduction in immune response.

Modified schedule for immunocompromised patients: Some guidelines recommend a shorter interval of 1-2 months between doses (rather than 2-6 months) for patients on immunosuppressants to achieve earlier protection. 2, 5

Step 3: Medication Holds (Optional, Based on Recent Guidelines)

Recent European guidance suggests considering holding azathioprine for 3 months before and 1 month after each Shingrix dose to optimize immune response. 2 However, this is not mandatory and should only be done if:

  • Your underlying disease is well-controlled
  • Your physician agrees it is safe to interrupt therapy
  • The benefit of enhanced vaccine response outweighs the risk of disease flare

In most real-world scenarios, you should receive Shingrix without interrupting azathioprine rather than delaying protection. 2, 3

Safety Profile and Expected Response

  • Common side effects: Injection-site pain, redness, swelling (9.5% grade 3 reactions), and systemic symptoms like fatigue and myalgia (11.4% vs 2.4% placebo). 5 These resolve within approximately 4 days. 2

  • Serious adverse events: No increased risk compared to placebo in large trials. 5, 4

  • Immune response: Your antibody response may be somewhat reduced compared to healthy individuals, but Shingrix still provides clinically meaningful protection even in immunosuppressed patients. 1, 3

  • Disease flares: Studies show only mild flares (4-17%) after Shingrix in patients with autoimmune conditions, with no serious adverse events. 2

Critical Pitfalls to Avoid

  1. Never receive Zostavax (live vaccine) while on azathioprine—this is contraindicated regardless of dose. 1, 2

  2. Do not delay vaccination to obtain antibody titers—serologic testing is not recommended before zoster vaccination in adults ≥50 years. 2

  3. Do not restart the series if you miss the second dose—there is no maximum interval; simply complete with a single second dose whenever possible. 2

  4. Do not confuse varicella (chickenpox) vaccine with zoster vaccine—if you've had chickenpox or shingles, you need the zoster vaccine, not varicella vaccine. 2

  5. If you previously received Zostavax, you still need the full 2-dose Shingrix series (wait at least 2 months after Zostavax). 2, 5

Why Vaccination Matters on Azathioprine

Patients on immunosuppressive therapy like azathioprine have a significantly increased risk of herpes zoster reactivation and are more likely to experience severe disease and complications like post-herpetic neuralgia. 6, 7 Shingrix reduces this risk by >90% in clinical trials and maintains efficacy >83% for at least 8 years. 2, 5

Bottom line: Schedule your first Shingrix dose now without interrupting azathioprine, and complete the second dose 2-6 months later (or 1-2 months if your physician prefers the accelerated schedule for immunocompromised patients). 2, 5, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Shingles Vaccination for Immunocompromised Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Shingrix Vaccination Guidelines for Immunocompromised Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

SHINGRIX Vaccination Schedule for Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Herpes Zoster During Immunosuppressive Therapy For Autoimmune Diseases.

Journal of Ayub Medical College, Abbottabad : JAMC, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.